Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis.
Baker J, Noguchi N, Marinovich ML, Sprague BL, Salisbury E, Houssami N.
Virchows Arch. 2022 Jan;480(1):65-84. doi: 10.1007/s00428-021-03182-7. Epub 2021 Nov 3.
PMID:34734332
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW.
Cancer Res Treat. 2022 Oct;54(4):1074-1080. doi: 10.4143/crt.2021.864. Epub 2021 Dec 21.
PMID:34942684
Impact of lobular carcinoma in situ on local recurrence in breast cancer treated with breast conservation therapy: a systematic review and meta-analysis.
Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast.
Ma BL, Rooks CO, Christopher WO, Berry SM.
Am Surg. 2023 Aug;89(8):3526-3527. doi: 10.1177/00031348231161080. Epub 2023 Mar 3.
PMID:36866802
Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G, Bianchi S, Kaya H, Amendoeira I, Querzoli P, Poli F, Scatena C, Cordoba A, Pietribiasi F, Kovács A, Faistova H, Cserni G, Quinn C.